Calumet Specialty Products Partners LP (CLMT) faced a significant sell-off on Tuesday, with its stock plummeting 16.79% amid heavy bearish options trading activity and an analyst price target downgrade.
The options market saw a surge in bearish bets against CLMT, with put options trading at 7 times the expected level. The most actively traded contracts were the February 2025 $16 and $12 put options, suggesting traders were positioning for further downside in the stock.
Additionally, UBS lowered its price target on CLMT from $24 to $20.50, while maintaining a Neutral rating on the stock. Despite the overall "Overweight" rating from analysts tracked by FactSet, with an average price target of $26.80, the downgrade likely added to the selling pressure on the stock.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。